EXICURE, INC. Shareholders' Equity
EXICURE, INC. (XCUR) had Shareholders' Equity of $977.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $977.00K.
- 2026-03-31: Stockholders' Equity Attributable to Parent $2.10M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $3.93M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $6.93M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $977.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.10M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $3.93M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $6.93M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $8.86M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $11.38M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $6.77M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $1.54M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $1.61M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $2.21M 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $3.03M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $4.50M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $9.71M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $14.62M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $14.92M 10-K · filed 2025-03-18 | |
| 2022-09-30 | -$3.70M 10-Q · filed 2024-05-16 | |
| 2022-06-30 | $1.16M 10-Q/A · filed 2024-06-06 | |
| 2022-03-31 | $3.24M 10-Q/A · filed 2024-06-06 | |
| 2021-12-31 | $11.23M 10-Q/A · filed 2024-06-06 | |
| 2021-09-30 | $13.98M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $36.64M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $50.04M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $61.51M 10-K · filed 2023-03-27 | |
| 2020-09-30 | $73.43M 10-Q · filed 2021-11-19 | |
| 2020-06-30 | $81.75M 10-Q · filed 2021-11-19 | |
| 2020-03-31 | $85.11M 10-Q · filed 2021-11-19 | |
| 2019-12-31 | $80.75M 10-K · filed 2022-03-25 | |
| 2019-09-30 | $64.95M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $11.39M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $16.16M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $20.95M 10-K · filed 2021-03-11 | |
| 2018-09-30 | $25.20M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $9.90M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $16.31M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $19.98M 10-K · filed 2020-03-10 | $18.95M 10-K · filed 2018-03-09 |
| 2017-09-30 | $11.68M 10-Q · filed 2017-11-14 | |
| 2017-08-31 | -$26.16K 10-Q · filed 2017-09-12 | |
| 2017-05-31 | -$20.13K 10-Q · filed 2017-07-11 | |
| 2017-02-28 | -$2.08K 10-Q · filed 2017-09-12 | |
| 2016-12-31 | $2.45M 10-K/A · filed 2019-09-23 | |
| 2015-12-31 | $18.23M 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |